Literature DB >> 24781195

Clinical impact of H-Y alloimmunity.

Rakesh Popli1, Bita Sahaf, Hideki Nakasone, Joyce Yeuk Yu Lee, David B Miklos.   

Abstract

H-Y antigens are a group of minor histocompatibility antigens encoded on the Y-chromosome with homologous H-X antigens on the X-chromosome. The disparate regions of the H-Y antigens are highly immunogenic and play an important role in understanding human alloimmunity. In this review, we investigate the history of H-Y antigen discovery along with their critical contributions in transplantation and pregnancy. In hematopoietic cell transplantation, male recipients with female donors who become seropositive for B-cell responses as H-Y antibodies following transplantation have increased rates of chronic graft-versus-host disease and decreased rates of relapse. Conversely, female patients who receive male kidney allografts are more likely than other gender combinations to develop H-Y antibodies and reject their allografts. Finally, in the setting of pregnancy, mothers who initially gave birth to boys are more likely to have subsequent pregnancy complications, including miscarriages, in association with H-Y antibody development. H-Y antigens continue to serve as a model for alloimmunity in new clinical scenarios. Our development of more sensitive antibody detection and next-generation DNA sequencing promises to further advance our understanding and better predict the clinical consequences of alloimmunity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781195      PMCID: PMC4380433          DOI: 10.1007/s12026-014-8514-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  104 in total

1.  Skin.

Authors:  E J Eichwald; C R Silmser
Journal:  Transplant Bull       Date:  1955

2.  The genetics of skin grafting.

Authors:  E J EICHWALD; C R SILMSER; N WHEELER
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

Review 3.  Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review.

Authors:  B Hutton; R Sharma; D Fergusson; A Tinmouth; P Hebert; J Jamieson; M Walker
Journal:  BJOG       Date:  2006-12-12       Impact factor: 6.531

4.  Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.

Authors:  M Markiewicz; U Siekiera; A Karolczyk; J Szymszal; G Helbig; J Wojnar; M Dzierzak-Mietla; S Kyrcz-Krzemien
Journal:  Bone Marrow Transplant       Date:  2008-10-13       Impact factor: 5.483

5.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

6.  Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.

Authors:  Fabrice Porcheray; David B Miklos; Blair H Floyd; Stefanie Sarantopoulos; Roberto Bellucci; Robert J Soiffer; Joseph H Antin; Edwin P Alyea; Jerome Ritz; Emmanuel Zorn
Journal:  Transplantation       Date:  2011-08-15       Impact factor: 4.939

7.  The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

Authors:  E H Warren; M A Gavin; E Simpson; P Chandler; D C Page; C Disteche; K A Stankey; P D Greenberg; S R Riddell
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

8.  Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.

Authors:  Assia Eljaafari; Ozel Yuruker; Christophe Ferrand; Annie Farre; Caroline Addey; Marie-Laure Tartelin; Xavier Thomas; Pierre Tiberghien; Elizabeth Simpson; Dominique Rigal; Diane Scott
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

9.  Sex mismatch in heart transplantation is associated with increased number of severe rejection episodes and shorter long-term survival.

Authors:  H Welp; T Spieker; M Erren; H H Scheld; H A Baba; J Stypmann
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

Review 10.  Active or passive immunization in unexplained recurrent miscarriage.

Authors:  Ole B Christiansen; Henriette S Nielsen; Bjorn Pedersen
Journal:  J Reprod Immunol       Date:  2004-06       Impact factor: 4.054

View more
  28 in total

1.  Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

Authors:  Hideki Nakasone; Bita Sahaf; Lu Tian; Tao Wang; Michael D Haagenson; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Fang Wu; Stephen R Spellman; Stephanie J Lee; Jerome Ritz; David B Miklos
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

2.  SNPs and prognosis of GvHD before HCT: any progress?

Authors:  M I Abu Zaid; S Paczesny; D B Miklos
Journal:  Bone Marrow Transplant       Date:  2015-10-12       Impact factor: 5.483

3.  High-throughput allogeneic antibody detection using protein microarrays.

Authors:  Jed Paul; Bita Sahaf; Spenser Perloff; Kelsi Schoenrock; Fang Wu; Hideki Nakasone; John Coller; David Miklos
Journal:  J Immunol Methods       Date:  2016-02-20       Impact factor: 2.303

4.  The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.

Authors:  Xiaomeng Hu; Simon T Kueppers; Nigel G Kooreman; Alessia Gravina; Dong Wang; Grigol Tediashvili; Stephan Schlickeiser; Marco Frentsch; Christos Nikolaou; Andreas Thiel; Sivan Marcus; Sigrid Fuchs; Joachim Velden; Hermann Reichenspurner; Hans-Dieter Volk; Tobias Deuse; Sonja Schrepfer
Journal:  Stem Cells Dev       Date:  2020-08-25       Impact factor: 3.272

5.  Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.

Authors:  Wei Wang; Hu Huang; Michael Halagan; Cynthia Vierra-Green; Michael Heuer; Jason E Brelsford; Michael Haagenson; Richard H Scheuermann; Amalio Telenti; William Biggs; Nathaniel M Pearson; Julia Udell; Stephen Spellman; Martin Maiers; Caleb J Kennedy
Journal:  Blood Adv       Date:  2018-10-09

6.  Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.

Authors:  Ariss DerHovanessian; Jamie L Todd; Alice Zhang; Ning Li; Aradhna Mayalall; C Ashley Finlen Copeland; Michael Shino; Elizabeth N Pavlisko; W Dean Wallace; Aric Gregson; David J Ross; Rajan Saggar; Joseph P Lynch; John Belperio; Laurie D Snyder; Scott M Palmer; S Sam Weigt
Journal:  Ann Am Thorac Soc       Date:  2016-05

7.  BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Authors:  Hideki Nakasone; Koji Kawamura; Kimikazu Yakushijin; Akihito Shinohara; Masatsugu Tanaka; Kazuteru Ohashi; Shuichi Ota; Naoyuki Uchida; Takahiro Fukuda; Hirohisa Nakamae; Ken-Ichi Matsuoka; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshihiro Inamoto; Sachiko Seo; Fumihiko Kimura; Masao Ogata
Journal:  Blood Adv       Date:  2019-06-11

8.  Donor-Recipient Weight and Sex Mismatch and the Risk of Graft Loss in Renal Transplantation.

Authors:  Amanda J Miller; Bryce A Kiberd; Ian P Alwayn; Ayo Odutayo; Karthik K Tennankore
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-30       Impact factor: 8.237

9.  Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Authors:  Hideki Nakasone; Lu Tian; Bita Sahaf; Takakazu Kawase; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Jed Paul; Rakesh Popli; Fang Wu; Joanne M Otani; John Coller; Edus H Warren; David B Miklos
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

10.  Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Authors:  Hideki Nakasone; Mats Remberger; Lu Tian; Petter Brodin; Bita Sahaf; Fang Wu; Jonas Mattsson; Robert Lowsky; Robert Negrin; David B Miklos; Everett Meyer
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.